Healthcare

  Empty capsules market accounted for US$ 2.42 billion in 2020 and is estimated to be US$ 5.00 billion by 2030 and is anticipated to register a CAGR of 7.50%. Empty is oral dosage forms, based on the type of manufacturing materials. Capsules are better than tablet because, there is no binding agent involved in keeping pill together. Capsules are either in form of soft or hard gels. Both the soft and hard gelatin are widely used in as empty capsules. Empty capsules are available in five sizes, and these capsules are differentiated on the basis of the amount of active pharmaceutical ingredient they can hold. The report  "   Global Empty Capsules Market, By Product Type (Gelatin Capsules (Pig Meat Gelatin, Bovine Meat Gelatin, Bone-derived Gelatin, and Others), Non-gelatin Capsules (Hydroxypropyl Methyl Cellulose (HPMC), Pullulan, and Starch Material), By Application (Antibiotics, Vitamins, Anti-inflammatory, Anti-anemic, and Others), By End User (Pharmaceutical Drugs Manufactures

    As Canadians are found to be suffering from different kinds of wounds, there has been an increase in the risk of infection and associated complications. Therefore, the use of wound dressings is to protect the wound and provide an optimal environment for wound repair. With traditional wound healing, dressings have substantially changed the wound outcome. Complications associated with surgical and chronic wounds are still a challenge to healthcare. Advancements in tissue engineering, biomaterial sciences, and stem cell biology have led to the development of novel dressings that not only dress the wounds but also actively contribute to the process of healing. With the advanced wound dressing has shown very significant results in diabetic patients as well in chronic wounds that take a long time or cannot be healed by traditional wound dressings. It revolves around the principle of moisture therapy, which provides moisture to the wound site to encourage natural cell repair while givi

  Bioprocess technology is the industrial application of biological processes to achieve desired substrate transformation using living cells or their constituent units, the main advantages of using bioprocesses over conventional chemical processes is that they produce renewable by-products. Bioprocessing is a combination of biology, mathematics and engineering that includes activities such as bioreactors, biocatalysts, substrates and media volume production, downstream processing and purification. Bioprocessing technology is likely to see significant demand from the pharmaceutical sector, due to the increasing incidence of chronic diseases such as infections and cancer. Bioprocess is a specific process that uses whole living cells or their components such as bacteria, enzymes, chloroplasts to obtain desired products. The most important applications of bioprocess-engineering research and development related to agriculture and food include yield, and biological pesticides and herbicides